Corteva, Inc. CTVA

NYSE Price as of Nov 10, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Jun 30, 2026

$12.18
$11.25
$90.97
Market cap
$8.13B
P/E (GAAP, TTM)
7.96
P/E (operating)
—
Dividend yield
0.9%
Revenue growth YoY
-1.2%
EPS growth YoY
-9.9%
ROIC
—
Piotroski F-score
6

Three ways to read the P/E

P/E (GAAP, TTM)
7.96

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
7.61

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
7.43

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) -1.2% 11.0%-12.2 pts 5.6%-6.8 pts
EPS growth YoY (qtr) -9.9% 12.6%-22.5 pts 27.2%-37.0 pts
Revenue growth (TTM) 3.7% 6.3%-2.6 pts 1.6%+2.1 pts
EPS growth (TTM) -25.7% 4.2%-30.0 pts 57.3%-83.0 pts
P/E (GAAP, TTM) 50.77 49.22+1.55 ——
P/E (operating) — —— ——
P/E (excl. gains) 48.38 52.73-4.35 ——
P/B 2.19 2.39-0.20 ——
ROIC — —— ——
Net margin 6.3% 6.3%0.0 pts 5.4%+0.9 pts
Dividend yield 0.9% 0.9%+0.1 pts ——
EPS (TTM) 1.53 1.72-11.0% 2.06-25.7%
Price $77.68 $84.66-8.2% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Jun 30, 2026 $6.38B 30.1% -1.2% 1.73 61.7% -9.9% 18.2%
Mar 31, 2026 $4.91B 25.4% 11.0% 1.07 233.8% 12.6% 14.7%
Dec 31, 2025 * $3.91B 49.4% -1.7% -0.80 -70.2% -1,500.0% -14.1%
Sep 30, 2025 $2.62B -59.4% 12.6% -0.47 -124.5% 38.2% -12.2%
Jun 30, 2025 $6.46B 46.2% 5.6% 1.92 102.1% 27.2% 20.4%
Mar 31, 2025 $4.42B 11.0% -1.7% 0.95 2,000.0% 58.3% 14.8%
Dec 31, 2024 * $3.98B 71.0% 7.3% -0.05 93.4% 85.7% -1.0%
Sep 30, 2024 $2.33B -61.9% -10.2% -0.76 -150.3% -68.9% -22.5%
Jun 30, 2024 $6.11B 36.1% 1.1% 1.51 151.7% 51.0% 17.2%
Mar 31, 2024 $4.49B 21.2% -8.0% 0.60 271.4% -27.7% 9.3%
Dec 31, 2023 * $3.71B 43.1% -3.1% -0.35 22.2% -400.0% -6.8%
Sep 30, 2023 $2.59B -57.2% -6.7% -0.45 -145.0% 2.2% -12.4%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 10, 2026 Date of the latest closing price used.
Price $12.18 Latest closing price.
Market cap $8.13B Price × shares outstanding.
Enterprise value $4.39B Market cap + debt − cash: the price of the whole business.
Shares 667.20M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) 7.61 Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) 7.96 Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) 7.43 Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG 18.12 P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield 13.5% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) 12.6% TTM EPS ÷ price.
P/B 0.34 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 0.47 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 0.46 Market cap ÷ revenue of the last four quarters.
P/FCF 2.89 Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA — Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales 0.25 Enterprise value ÷ revenue.
Book value / share 36.19 Shareholders' equity ÷ shares.
FCF yield 34.6% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS — After-tax operating income per share (latest fiscal year).
Investment gains — Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains — One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income — Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income 0.0% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Jun 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $6.38B Revenue of the latest reported quarter.
Net income (qtr) $1.16B Net income of the latest reported quarter.
EPS (qtr) 1.73 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) -1.2% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) 30.1% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) -9.9% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) 61.7% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -11.6% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) 61.3% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) — Operating income ÷ revenue in the latest quarter.
Net margin (qtr) 18.2% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $17.81B Revenue of the last four quarters.
Net income (TTM) $1.01B Net income of the last four quarters.
EPS (TTM) 1.53 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) 3.7% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) -25.7% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) -28.0% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.9% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) $0.1080 Dividends per share paid over the last 12 months.
Payout ratio 6.8% Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio 16.9% Dividends ÷ free cash flow.
Dividend growth (1y) 4.3% Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) 16.1% Annualised dividend growth over 3 years.
Dividend CAGR (5y) 1.4% Annualised dividend growth over 5 years.
Payments (12m) 4 Number of dividend payments in the last 12 months.
Last ex-dividend date Sep 1, 2026 Most recent ex-dividend date.
Buyback yield 13.2% Share repurchases ÷ market cap.
Shareholder yield 14.1% Dividend yield + buyback yield.
Profitability
Gross margin 47.3% Gross profit ÷ revenue (latest fiscal year).
EBITDA margin — EBITDA ÷ revenue.
Operating margin — Operating income ÷ revenue.
Net margin 6.3% Net income ÷ revenue.
FCF margin 16.2% Free cash flow ÷ revenue.
ROE 4.5% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA 2.6% Return on assets: net income ÷ total assets.
ROIC — Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 2.9% Latest fiscal year revenue vs the year before.
Net income growth (annual) 20.6% Latest fiscal year net income vs the year before.
EPS growth (annual) 23.1% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) -0.1% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) 0.4% Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 1.43 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 0.96 (Current assets − inventory) ÷ current liabilities.
Cash ratio 0.37 Cash ÷ current liabilities.
Debt / equity 0.03 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.02 Total debt ÷ total assets.
Debt / EBITDA — Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA — (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage — Operating income ÷ interest expense.
Earnings quality
FCF conversion 257.3% Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -5.4% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue — Share-based compensation ÷ revenue.
R&D % revenue 8.5% Research & development spending ÷ revenue.
SG&A % revenue 20.1% Selling, general & administrative expense ÷ revenue.
Tax rate used 28.7% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.41 Revenue ÷ total assets.
Days sales outstanding 102 Average days to collect payment from customers.
Days inventory 226 Average days inventory is held.
Days payables 175 Average days to pay suppliers.
Trading & momentum
52-week high $90.97 Highest price in the last 52 weeks.
52-week low $11.25 Lowest price in the last 52 weeks.
From 52-week high -86.6% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 8.3% How far above the 52-week low the price is.
Avg volume (30d) 12.53M Average shares traded per day over the last 30 days.
Avg $ volume (30d) $154.16M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 6 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score — Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $17.40B Revenue of the latest fiscal year.
Net income $1.09B Net income of the latest fiscal year.
Diluted EPS 1.60 Diluted earnings per share of the latest fiscal year.
EBITDA — Operating income + depreciation & amortization.
Free cash flow $2.82B Operating cash flow − capital spending.
Total debt $782.00M Long-term plus current debt.
Cash $4.52B Cash and equivalents.
Equity $24.14B Shareholders' equity.
Total assets $42.85B Total assets.